Skip to main content
No.1 Press Release Service in Korea
Search
Search
Login
Create Account
Services
Contact Us
News
Services
About Us
Contact Us
Korean
News
All News
News by Region
Korea
Overseas
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Services
Why Korea Newswire?
How We Distribute
Services & Pricing
Basic
Standard
Premium
Global
Translation
Press Release Network in Korea
Korean Language
About Us
News
Services
Contact Us
Search
Cancel
Search
Submit Press Release
Latest News
News by Region
Korea
World
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Health News Releases
Today May 21
March 29, 2022 11:00
The Medi-Globe Group opens the MGG Campus - a new training and virtual test laboratory
The Medi-Globe Group has opened its own training and virtual test laboratory at its headquarters in Achenmühle, Germany. The Medi-Globe Group Campus (MGG Campus) has state-of-the-art equipment with wh
March 28, 2022 15:00
Publication of definitive end result for Vifor Pharma tender offer
CSL Behring AG, Berne, Switzerland, a wholly-owned subsidiary of global biotechnology leader CSL Limited (ASX: CSL; USOTC: CSLLY), today announced the definitive notice of the end result of its public
March 28, 2022 11:45
Galderma to Highlight Latest Science and Innovation Across Its Product Portfolio at the 2022 AAD Annual Meeting
Galderma, the leading company solely dedicated to advancing the future of dermatology, announced it will be attending the 2022 American Academy of Dermatology Annual Meeting to showcase its latest app
March 28, 2022 10:00
STALICLA Completes Successful Phase 1b Trials for the First Precision Medicine in Autism Spectrum Disorder
STALICLA, a Swiss clinical stage biotech company leading omics-based drug development for patients with neurodevelopmental disorders (NDDs), announced today the highly successful completion of the pha
March 25, 2022 15:40
Tanner Pharma Increases Europe-Based Inventory of Leukine® to Expand Availability and Enhance Response to Potential Radiation Exposure Due to the Ongoing Conflict in Ukraine
Tanner Pharma Group, an international distributor of essential medicines, announced that it has significantly increased its inventory of Leukine (sargramostim, yeast-derived rhuGM-CSF) to be held in E
March 25, 2022 09:40
ViiV Healthcare announces label update for its long-acting HIV treatment, Cabenuva (cabotegravir, rilpivirine), to be initiated with or without an oral lead-in period
For media and investors only ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today announced
March 23, 2022 16:40
Publication of provisional end result for Vifor Pharma tender offer: Participation rate of 94 percent
Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220322006149/en/ AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL B
March 23, 2022 14:55
Alchemab Selected to Access NVIDIA Cambridge-1 Supercomputer to Advance Machine Learning Enabled Antibody Discovery
Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies and immune repertoire-based patient stratification tools, has been
March 22, 2022 09:02
Dental Prosthetics Sales In Asia Pacific To Top With A Market Valuation of More Than USD 50 Bn by 2030; Owing To The Rising Trends of Cosmetic Dentistry: Fact.MR
According to Fact.MR Latest Analysis, the global dental consumables market is projected to register growth at the rate of nearly 4% over the forecast period of 2020-2030, to reach a market valuation o
March 21, 2022 10:10
No Virus Transmission Detected at 300 Stores With Seoul Viosys UVC Air Purifying Sterilizer
Seoul Viosys (KOSDAQ: 092190), a global optical semiconductor company, provided free air purifying sterilizers applied with Violeds, its UV LED sterilization solution technology, to more than 300 self
March 17, 2022 16:30
Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online Traffic
Gelesis (NYSE: GLS), the maker of Plenity, announced preliminary results from its broad awareness media campaign that debuted January 31, 2022. Within the first three weeks, the company saw a 3-fold i
March 17, 2022 11:35
More Than Half of Physicians Have Been Asked By Patients for an Unapproved COVID-19 Treatment
A new survey from Sermo, a physician-first online community and leader in global HCP insights, found that physicians are facing a challenging onslaught of COVID-19 vaccine and treatment misinformation
March 17, 2022 10:15
Jardiance® (empagliflozin) Phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease
The EMPA-KIDNEY trial, evaluating the effect of empagliflozin in adults with chronic kidney disease (CKD), will stop early based on a recommendation from the trial’s Independent Data Monitoring Commit
March 16, 2022 21:05
Aleph Farms Reveals Its Strategy to Replace the Whole Cow as an Alternative to Intensive Cattle Farming
Aleph Farms, the first company to grow cultivated beef steaks, today announced it is expanding its product line to include a unique platform for cell-cultured collagen production. The company’s highly
March 16, 2022 09:07
Smartphone Penetration Is Encouraging The Mindfulness Meditation Apps Usage And Is Expected To Top With A Sales Volume of 180 Mn Latest Study By Fact.MR
As per the analysis conducted by Fact. MR, the global mindfulness meditation apps market is anticipated to procure a market value of USD 180 Mn through 2032. The increasing cases of depression, mood d
March 15, 2022 14:40
Dexcom G7 Receives CE Mark - Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today it has secured CE Mark (Conformité Européenne) for the Dexcom G7 Cont
March 15, 2022 11:10
Nichi GLOW: Japanese Beta-Glucan, in Children With Autism Spectrum Disorder, Improves Behavior, Sleep, and Gut Microbiome in a Clinical Study
In the first such report, children with Autism spectrum disorder (ASD) showed improvement in behaviour, learning skills and sleep, after oral consumption of AFO-202 strain of black yeast Aureobasidium
March 14, 2022 16:20
Join KOREA PACK & ICPI WEEK 2022 to Be Held June 14 - 17, KINTEX, Korea!
KOREA PACK and ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry Week), the largest packaging, cosmetic and pharmaceutical exhibition in Korea, will be held at KINTEX from June 14th to 17th as hyb
March 11, 2022 18:04
Blood Cancer Biomarkers Market: Why Is It Expected That The Asian Market Will Outperform Others, Detailed Study By Fact.MR
According to Fact.MR’s Study, the cancer biomarkers market revenue is anticipated to surpass US$ 33 Bn by 2031, representing a 3x increase from 2020. Presently, the market is valued at a little above
March 10, 2022 11:45
Dr. Andreas Amrein Joins Advanced Clinical to Lead Global Development and Expansion in APAC, Europe and Canada
Advanced Clinical, a clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey, is pleased to announce that Dr.
March 10, 2022 09:40
Alvotech Resolves U.S. Patent and Trade Secret Disputes with AbbVie, Securing U.S. Rights for Alvotech’s Proposed High-Concentration Biosimilar (AVT02) for Humira®
Alvotech Holdings S.A. (“Alvotech”), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, announced today that is has ex
March 09, 2022 09:30
Medical Ventilators Market to exhibit a CAGR of 9.1% during the forecast period 2022-2030: Future Market Insights
Greater emphasis on ramping up the production to address a sudden increase in demand in the time of COVID-19 pandemic is accelerating the growth of the medical ventilators market. The global medical v
March 09, 2022 08:45
ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient Enrolled in the Clinical Trial for Opioid Sparing in Participants with Radiculopathic Pain
ANANDA Scientific Inc., a biotech pharmaceutical company, and NYU Grossman School of Medicine today announced that the first patient has been enrolled in a clinical trial evaluating Nantheia™ A1002N5S
March 08, 2022 17:05
Publication of definitive Interim Result for Vifor Pharma tender offer: CSL Behring AG declares offer successful
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL Behring AG, Berne, Switzerland, a wholly-owned subsidiary of global biotechnology leader CSL Limited (ASX: CSL; USOTC: CSLLY), tod
March 08, 2022 16:40
Mawi DNA Technologies Nabs CE Certification for Sample Collection Product Portfolio
Mawi DNA Technologies (Mawi), a leader in biosample collection technologies, announces the company received CE Mark and UK MHRA approval for its portfolio of iSWAB non-invasive collection devices. Thi
March 08, 2022 10:41
STR 2022 to Be Held March 19th-23rd and AI-based Lung Disease Diagnosis Sessions Presented
The Society of Thoracic Radiology (STR) will hold the 40th annual meeting and conference at Caesar’s Palace in Las Vegas, Nevada from March 19 to 23, 2022. The STR conference is an event where sch
March 07, 2022 16:40
Jardiance® (empagliflozin) becomes the first and only approved treatment in Europe for adults with symptomatic chronic heart failure regardless of ejection fraction
The European Commission (EC) has granted marketing authorization for Jardiance® (empagliflozin) as a treatment for adults with symptomatic chronic heart failure, Boehringer Ingelheim and Eli Lilly and
March 07, 2022 10:16
GI Innovation Forms Co-representative System by Recruiting CEO Byung-Geon Rhee, Former CEO of GC Pharma and SCM Lifescience
GI Innovation, a new innovative drug development company, announced on March 4th that it has recruited Chief Executive Officer (CEO) and Chairman, Byung-Geon Rhee, former CEO of GC Pharma, SCM Lifesci
March 04, 2022 13:50
Hologic Partners With the WTA Tour in Landmark Title Sponsorship
The WTA and Hologic today jointly announced a landmark partnership introducing Hologic as the global title sponsor of the WTA Tour. The multi-year alliance, the largest global sponsorship in WTA hi
March 04, 2022 11:20
The OPTRACT Method: Efficient Human Donor Cornea Transportation Feat & Futuristic Cell Repository in Zero-gravity for Space-age, Anti-aging Research; Strategy by Japanese Scientists.
A much efficient human cadaver donor-corneal transportation method, developed by Japanese scientists, may increase the availability of donated eyes to millions of patients with corneal blindness, wait
March 03, 2022 17:30
Publication of provisional interim result for Vifor Pharma tender offer: Participation rate of 74 percent
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL Behring AG, Berne, Switzerland, a wholly-owned subsidiary of global biotechnology leader CSL Limited (ASX: CSL; USOTC: CSLLY), to
March 03, 2022 17:15
Allscripts to Sell the Net Assets of Its Hospitals & Large Physician Practices Business Segment to Constellation Software
Allscripts Healthcare Solutions (NASDAQ: MDRX) (“Allscripts”) announced today that it has reached an agreement with Constellation Software Inc. (TSX:CSU), through its wholly-owned subsidiary N. Harris
March 02, 2022 10:15
Interim Phase 4 Data Support TAKHZYRO® (lanadelumab) as an Effective Treatment to Reduce Attacks in Hereditary Angioedema Patients
Takeda (TSE:4502/NYSE:TAK) today presented four abstracts including interim real-world data from the observational Phase 4 EMPOWER study of TAKHZYRO® (lanadelumab) as a treatment for people with Hered
March 02, 2022 10:15
FDA Accepts Alvotech’s BLA Supporting Interchangeability for ATV02, a High Concentration, Citrate-Free Biosimilar Candidate for Humira®
Alvotech Holdings S.A. (“Alvotech”), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, announced today that the U.S.
March 02, 2022 10:05
Glucophage® Is the First Oral Diabetes Treatment Approved in Europe for Use During Pregnancy
Merck, a leading science and technology company, today announced in a European worksharing procedure (WSP) an extension to the label for metformin products in the EU - Glucophage® (metformin hydrochlo
February 28, 2022 15:40
Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodialysis patients
Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220227005069/en/ Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
February 28, 2022 09:49
Oncocross Begins Phase I Clinical Trial of AI-Developed Drug for Sarcopenia
Oncocross, an AI-based drug development biotech, announced that it initiated a phase I global clinical trial for ‘OC514’ targeting muscular diseases including sarcopenia. Oncocross obtained Austral
February 25, 2022 11:00
GliaPharm SA and the Wyss Center Enter Collaboration to Develop New Therapies for Alzheimer’s Disease
GliaPharm SA, a biotech company that specializes in the research and development of novel therapies to treat and prevent neurological diseases, and the Wyss Center, a non-profit organization dedicated
February 25, 2022 10:34
GI Innovation and Cellkey to Develop Next-generation Innovative Immuno-oncology through Biomarker Joint Research
GI Innovation, an innovative new drug development company, announced that it signed a biomarker joint research MoU with CellKey, a Glycoprotein biomarker development company, to develop next-generatio
February 25, 2022 09:25
New MAVENCLAD® Data at ACTRIMS Forum 2022 Show Favourable Efficacy Outcomes Versus Other Oral DMTs and Lower Occurrence of Further Relapses or Disability Progression
Merck, a leading science and technology company, today announced new real-world data from the MSBase Registry demonstrating MAVENCLAD® (cladribine tablets) had more favourable relapse outcomes and lon
February 24, 2022 10:00
Protein Hydrolysate Ingredients Market is expected to reach USD 1.0 Billion by 2031, growing at a CAGR of 7.30% during 2021- 2031: Future Market Insights
The global sales of protein hydrolysate ingredients are expected to grow by 6.80% in 2021, reaching 33,268 MT in terms of volume. Future Market Insights (FMI) forecasts that the protein hydrolysate in
February 23, 2022 16:40
rf IDEAS and Key Partners to Spotlight Healthcare IAM Solutions at HIMSS22
rf IDEAS, a global leader in the design and manufacture of credential readers for authentication and logical access, will be on site at the HIMSS22 Conference in Orlando, Florida (Booth #1313) with ke
February 23, 2022 11:43
Taro to Acquire Alchemee From Galderma
Galderma and Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) announced today they have signed a definitive agreement for Taro to acquire Alchemee, formerly The Proactiv Company (TPC), from G
February 23, 2022 10:50
Kaneka Eurogentec Announces the Successful Production of 25g of mRNA in One Batch
Kaneka Eurogentec, an FDA inspected contract development and manufacturing organization (CDMO), announced today that its mRNA manufacturing facility has successfully produced a 25 g batch of mRNA for
February 23, 2022 10:00
Laboratory Information Systems Market is slated to increase at a CAGR of 10.2% to reach a valuation of USD 4.2 Billion by 2030: Future Market Insights
Global laboratory information system (LIS) market revenues are set to grow at 10.2% CAGR through 2030, according to an updated edition by Future Market Insights (FMI). The 2022-2030 version of the rep
February 22, 2022 16:00
Regencell Bioscience’s Investigational Liquid-Formula RGC-COV19TM Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial
Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”) today announced the results from an analysis of a total of 37 individuals enrolled in its Evaluation and Assessment o
February 22, 2022 15:54
Advanced Wound Management Market is projected to grow at a steady pace, exceeding a market valuation of USD 6.5 Billion between 2021 and 2031: Future Market Insights
Growing investments in the healthcare sector, coupled with innovations in advanced wound management products are anticipated to positively shape demand in the upcoming years. With an increasing inc
February 21, 2022 11:55
European Commission Approves TEPMETKO® (tepotinib) for Patients with Advanced NSCLC with METex14 Skipping Alterations
Merck, a leading science and technology company, today announced that the European Commission (EC) has approved once-daily oral TEPMETKO® (tepotinib) as monotherapy for the treatment of adult patients
February 21, 2022 11:30
Long-Term Follow-Up Data Reinforce Continued Overall Survival Benefit of BAVENCIO® (avelumab) First-Line Maintenance Treatment in Patients with Advanced Urothelial Carcinoma
Merck, a leading science and technology company, today announced the results of an exploratory analysis from the Phase III JAVELIN Bladder 100 trial with 19 additional months of follow-up data from th
February 21, 2022 10:35
Alofisel®▼ (darvadstrocel) Shows Clinical Remission Rate at Six-Months in the Real-World INSPIRE Study Interim Analysis Consistent with the Pivotal Clinical ADMIRE-CD Study[1,2]
Takeda (TSE:4502/NYSE:TAK) today announced the first six-month interim analysis results from INSPIRE, in which clinical remission[*] was observed in 65% of patients in both cohorts who were evaluated
February 18, 2022 16:28
Karen L. Ling joins Galderma’s Advisory Committee
Galderma, the world’s largest independent dermatology company, announced today that Karen L. Ling will join its Advisory Committee, effective March 1, 2022. Karen Ling has a tremendous track record
February 18, 2022 09:10
NEC OncoImmunity Publishes a Unique HLA Typing Technology That Discovers New HLA Alleles, and Tumor Specific HLA Alleles
NEC OncoImmunity AS (NOI) today announced a publication that describes a novel approach to type new HLA alleles and characterize the HLA of tumors to guide personalized cancer immunotherapy. The co
February 17, 2022 15:20
Vifor Pharma reports sustained growth in 2021
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma Group reported a solid performance in 2021 and an increase in profitability, supported by a strong recovery in Ferinject®
February 17, 2022 11:40
Organon Acquires Contraceptive Products, Marvelon® and Mercilon®, in the People’s Republic of China, including Hong Kong and Macau, and Agrees to Acquire these Products in Vietnam
Organon (NYSE: OGN) today announced that it has acquired the rights from Bayer AG to Marvelon® and Mercilon®, combined oral hormonal daily contraceptive pills, in the People’s Republic of China, inclu
February 17, 2022 10:21
Capsa Healthcare Announces the Acquisition of Humanscale Healthcare
Capsa Healthcare, a leading innovator in healthcare delivery solutions for hospitals, long-term care, and retail pharmacy providers, announced the acquisition of Humanscale Healthcare, a designer and
February 16, 2022 11:46
Medidata Opens Access to its Patient Insights Program, Enabling Sponsors and CROs to Leverage Proprietary Patient Centricity by Design Process for Clinical Trials
Medidata, a Dassault Systèmes company, today announced it is allowing sponsors, CROs (contract research organizations), and sites to leverage its proprietary Patient Centricity by Design process for c
February 16, 2022 11:43
BreastScreen Victoria Switches to Rimini Street Support for its Oracle Database Software, Unlocks Resources to Meet Increasing Service Demand
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partn
February 16, 2022 10:03
German Federal Court of Justice Upholds AOP‘s License Rights in Ropeginterferon and PEC’s Liability for Damages.
Since 2017, PharmaEssentia had repeatedly attempted to terminate the agreement with AOP concerning BESREMi® (Ropeginterferon alfa-2b). In October 2020, after two and a half years of arbitral proceedin
February 15, 2022 10:30
Mawi DNA Technologies Awarded Two ISO Certifications
Mawi DNA Technologies (Mawi), a leading biosampling collection company, announces it has been awarded the ISO 9001:2015 Quality Management Systems and ISO 13485:2016 Medical Devices Quality Management
February 11, 2022 09:00
Vision Care Market is projected to account for over USD 127.73 Bn, in terms of value, by 2028 end: Future Market Insights
The increasing usage of electronic devices, changing lifestyle and hygiene have led to vision-related problems worldwide. The number of patients with vision-related problems has increased and so is th
February 09, 2022 16:15
Theramex Reinforces its Commitment to Women on International Women’s Day
International Women’s Day is an important date on the calendar to recognise and celebrate the social, economic, culture, political, scientific and many more achievements of women globally. At Theramex
February 09, 2022 13:55
Mandy Moore Partners With Lumenis to Raise Awareness of Dry Eye Disease and OptiLight Treatment
Lumenis today announced that it has partnered with singer-songwriter and actress Mandy Moore as a brand ambassador for OptiLight, a bright solution for dry eyes. Ms. Moore suffered from dry eye diseas
February 08, 2022 15:55
Cook Medical Reproductive Health Business to be Acquired by CooperCompanies
Cook Medical today announced it signed a letter of intent with CooperCompanies to sell the entirety of Cook’s Reproductive Health business within the MedSurg division. CooperCompanies (NYSE:COO), a pu
February 07, 2022 13:50
Takeda Delivers Strong Third Quarter FY2021 Results and Raises Full-Year Forecast Reflecting Strong Momentum
Takeda (TOKYO:4502/NYSE:TAK) today announced strong financial results for the third quarter of its fiscal year 2021 (period ended December 31, 2021) driven by robust topline growth of its 14 global br
February 07, 2022 10:30
Parexel Extends Strategic Partnership with Medidata to Enhance Delivery of Decentralized Clinical Trials
Medidata, a Dassault Systèmes company, announced today that Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance pa
February 04, 2022 16:00
Dr. Reddy's Laboratories Enters Into Definitive Agreement to Acquire German Medical Cannabis Firm Nimbus Health GmbH
Dr. Reddy‘s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced that it has entered into a def
February 03, 2022 17:10
Organon Declares Paid Time Off for All Employees on International Women’s Day; Employees to Focus on Their Own Health in Recognition of Growing Women’s Health Inequity
Organon (NYSE: OGN), a global women’s health company, is designating International Women’s Day (IWD) on March 8 as a day to recognize the growing health disparities women face that have been exacerbat
February 03, 2022 14:40
Following LSNE Acquisition, PCI Pharma Services Continues to Expand Sterile Fill-Finish Expertise with State-of-the-Art Equipment
PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced the addition of three new exceptional automated sterile fill-finish machines in
February 03, 2022 11:30
Third-Party Clinical Study Documents Industry-Leading Long-Term Safety Record and Patient Satisfaction for GC Aesthetics Breast Implants
GC Aesthetics, Ltd. (GCA), a privately held medical technology company providing aesthetic and reconstructive solutions for global healthcare markets, has announced the results of an independent clini
February 03, 2022 09:35
Vifor Pharma appoints two new members to the Executive Committee
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma Group today announced the appointment of acting Chief Financial Officer Alexandros Sigalas and Group General Counsel Dr.
February 03, 2022 09:30
Waters Acquires Charge Detection Mass Spectrometry Technology to Broaden its Application in Cell and Gene Therapy
Waters Corporation (NYSE:WAT) today announced it has acquired the technology assets and intellectual property rights of Megadalton Solutions, Inc., an early-stage developer of Charge Detection Mass Sp
February 02, 2022 15:00
Juvenescence Ltd. Portfolio Company Hails Successful Limb Regeneration in Adult Frogs
Morphoceuticals Inc., a portfolio company of Juvenescence Ltd., hailed the results of a long-term study published by its founders in Science Advances showing the successful regeneration of limbs in Xe
February 02, 2022 13:40
In the 2022 PQE Group Agenda: Boosting Internationalization by Hiring 800 Talents
It has been another successful year for PQE Group, a consulting firm in the LifeScience industry based in Florence (Italy) with 27 offices worldwide. Recently named “Best Managed Company” by Deloitte,
February 02, 2022 13:20
Monrol Signing Agreement to License its GMP Grade Lu-177 n.c.a Production Technology to Curium
Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) has today announced it has signed an agreement with Curium Netherlands B.V (Curium) to license its GMP grade medical radioisotope, no-carrier-added 177L
February 02, 2022 12:00
CHMP issues positive opinion to expand Jardiance (empagliflozin) indication based on unprecedented benefit in adult heart failure patients with preserved ejection fraction
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending Jardiance® (empagliflozin) for the treatment of adults with
January 28, 2022 09:45
Gender, health and racial inequalities to be tackled in flagship Ferring grant programme
Forensic analysis of stone age human fertility to better understand why modern-day sperm counts are falling, and a project to support safe birth in rural Ethiopia by providing trained midwives and sol
January 27, 2022 17:20
Covetrus Taps César França as President, Global Proprietary Brands
Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of César França as President, Global Proprietary Brands. França will lead the com
January 27, 2022 15:45
ABO - Óskare Capital: Partnership Announcement
Alpha Blue Ocean (ABO) and Óskare Capital are announcing today the formation of a strategic partnership to collaborate on investment opportunities associated with cannabis plant-based medicines as wel
January 26, 2022 09:00
UVD Robots Joins Ecolab’s Global Infection Prevention Offerings to Fight Hospital Acquired Infections
As new coronavirus variants spread, the growth in demand for infection prevention solutions using UV-C light is projected to reach $18.94 billion by 2030, witnessing an annual growth rate of 59.7% fro
January 25, 2022 17:00
Prospection and Novotech Partner To Accelerate Clinical Trials With Real World Evidence
Global healthcare data technology company, Prospection, and leading Asia-Pacific biotech specialist CRO, Novotech Health Holdings, announce a strategic partnership to combine the power of real world e
January 21, 2022 12:00
Mavenir Brings Dynamic Network Slicing Innovation Through TM Forum Catalyst Ecosoft eHealth Program
Mavenir, the Network Software Provider building the future of networks with cloud-native software that runs on any cloud and transforms the way the world connects, today announced successful completio
January 20, 2022 17:05
Award: Boehringer Ingelheim is Global Top Employer 2022
The Top Employers Institute awarded Boehringer Ingelheim for the second year in succession a “Global Top Employer”, one of the world’s eleven best employers. The award shows that the research-driven p
January 20, 2022 10:00
VFMCRP receives EU approval for Tavneos® for the treatment of ANCA-associated vasculitis
Regulatory News: Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced that the European Commission has approved Tavneos® in combination with a rituximab or cyclophosphamide regimen fo
January 20, 2022 09:00
Adoption of Microchip-Based Technology in Liquid Biopsy to Spur the Sales at 13.49% CAGR through 2031: Future Market Insights
As per a recent market survey by ESOMAR-certified consulting firm Future Market Insights (FMI), the global liquid biopsy market is expected to reach a market valuation of US$ 1,026 Mn in 2021. With
January 18, 2022 21:00
BiologyWorks k(now)™ COVID-19 Clinical Trial Matches 99.1% Accuracy to RT-PCR Tests
BiologyWorks™, Inc., a digital healthcare platform company, today announced that a substantive clinical trial of its handheld, reusable molecular test for COVID-19 matched 99.1% accuracy to laboratory
January 18, 2022 15:50
CSL Behring AG publishes Offer Prospectus on public tender offer for all publicly held shares of Vifor Pharma Ltd.
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL Behring AG, Berne, Switzerland, a wholly-owned subsidiary of global biotechnology leader CSL Limited (ASX: CSL; USOTC: CSLLY), tod
January 14, 2022 11:10
Mary Kay Continues Its Commitment to Skin Science
Mary Kay Inc., one of the world’s innovative skincare companies, participated at two renowned European conferences in late 2021. At the 19th Aesthetic & Anti-Aging Medicine World Congress, Mary Kay In
January 13, 2022 11:10
Liverpool CCG and Community Pharmacy Liverpool Launch FebriDx® Service at More Than 100 Community Pharmacies
Today, Liverpool Clinical Commissioning Group (CCG) and Community Pharmacy Liverpool kicked off a new clinical service that will allow more than 100 pharmacies to offer a 10-minute, point-of-care test
January 13, 2022 10:30
Headspace Health Announces Acquisition of AI-Driven Mental Health and Wellness Company, Sayana
Headspace Health, the provider of the world’s most accessible, comprehensive digital mental health platform, today announced the acquisition of Sayana, an AI-driven mental health and wellness company.
January 12, 2022 17:30
Medisca Signs Deal as Exclusive Global Distributor outside the USA & Israel for the Padagis Line of ORA Products
On December 9, 2021, Medisca entered into an exclusive global manufacture, supply, license and distribution agreement with Padagis (formerly, the Rx Division of Perrigo) for their ORA Product Line con
January 12, 2022 14:35
Sales of Needle-Free Injectors Set to Rise by 11.4% CAGR as Application Soars in Response to Increasing Cases of Diabetes Worldwide: Future Market Insights
According to the latest study by Future Market Insights (FMI), global Needle-Free Injectors’ sales are expected to reach US$ 12.3 Bn in 2021, surging at 11.4% CAGR during the forecast period (2021-203
January 11, 2022 14:50
Takeda Emphasizes Strategy for Delivering Sustainable Growth Over Next Decade at the 40th Annual J.P. Morgan Healthcare Conference
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today confirmed the company is positioned for growth in the mid- and long-term with the potential to deliver incremental revenue gr
January 11, 2022 11:50
Takeda to Acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta (γδ) T Cell Engager Therapies Targeting Solid Tumors
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the exercise of its option to acquire Adaptate Biotherapeutics (“Adaptate”), a UK company focused on developing ant
January 11, 2022 10:10
QUANTA Dialysis Technologies Appoints Meghan Fitzgerald and Leslie Norwalk to Board of Directors
QUANTA Dialysis Technologies Ltd (“QUANTA” or the “Company”), a medical technology company committed to making dialysis more accessible with its SC+ hemodialysis system, today announced that Meghan Fi
January 10, 2022 17:30
Iksuda Therapeutics Deepens Clinical Pipeline Through Licensing Agreement for Her2 Antibody Drug Conjugate Programme From LegoChem Biosciences
Iksuda Therapeutics (Iksuda), the developer of a new generation of antibody drug conjugates (ADCs) with raised therapeutic index, today announced further expansion of its differentiated ADC pipeline t
January 07, 2022 13:40
Leman Micro Devices: World-first Clinical Trial Proves Cuffless Mobile Device Sensor and App Measures Blood Pressure With Same Accuracy as Cuff-based Machines
Leman Micro Devices’ e-Checkup system has successfully completed a world-first clinical trial and proven it is the only completely cuffless and calibration-free sensor and app capable of measuring blo
January 06, 2022 14:45
FDA Accepts Samsung Bioepis’ and Organon’s sBLA for their Citrate-Free, High-Concentration HUMIRA® (Adalimumab) Biosimilar Candidate
Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE: OGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) f
January 05, 2022 17:20
Galderma Successfully Completes Acquisition of ALASTIN Skincare®
Galderma, the world’s largest independent dermatology company, announced today that it has received antitrust clearance from the U.S. authorities and has completed the acquisition of ALASTIN Skincare®
January 04, 2022 21:05
ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)
ANANDA Scientific Inc., (a biotech pharma company) today announced approval by the U.S. Food and Drug Administration (FDA) of the Investigational New Drug (IND) application for the clinical trial eval
January 04, 2022 09:55
Celltrion announces positive results for its cocktail therapy candidates including neutralisation data against Omicron variant
Celltrion Group announced today results for its cocktail therapy candidates including neutralisation data against the Omicron variant (B.1.1.529). The Phase I clinical trial is a randomised, double
«
7
8
9
10
11
»
100 per page
25 per page
50 per page
75 per page
100 per page
Distribute Your News to
KOREA
The largest press release distribution network in Korea
34,000 journalists
7,000 media outlets
345 industry channel
80,000 subscribers
Get Started
Global PR service
Reach Your Target
Audience in 160 Countries
powered by
Get Started
News by region
Korea
Overseas
News by industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Notice